Cite
MLA Citation
Filip Baert et al.. “Antibodies to adalimumab are associated with future inflammation in Crohn's patients receiving maintenance adalimumab therapy: a post hoc analysis of the Karmiris trial.” Gut, vol. 65, no. 7, 2016, pp. 1126–1131. http://access.bl.uk/ark:/81055/vdc_100135151331.0x00003f